StonvexLoading…
StonvexStonvexStonvexCore line items from ESCA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $55.78M | $240.16M | $177.60M | $109.81M |
Operating Income | $5.83M | $18.73M | $13.57M | $6.27M |
Net Income | $4.38M | $13.70M | $10.00M | $4.44M |
EPS (Diluted) | $0.32 | $0.99 | $0.72 | $0.32 |
Total Assets | $227.55M | $222.11M | $232.46M | $218.34M |
Total Liabilities | $51.71M | $48.89M | $60.13M | $50.00M |
Cash & Equivalents | $13.05M | $11.88M | $3.51M | $10.42M |
Free Cash Flow OCF − CapEx | $5.29M | $28.50M | $14.85M | $16.11M |
Shares Outstanding | 13.76M | 13.70M | 13.70M | 13.80M |